Scholars@Duke

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.

Publication ,  Journal Article
Kuderer, NM; Burton, KA; Blau, S; Rose, AL; Parker, S; Lyman, GH; Blau, CA
Published in: JAMA Oncol
July 1, 2017
Published version (DOI) Link to item

This study compares reports from 2 next-generation sequencing tests to determine the level of concordance between platforms.

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

JAMA Oncol

DOI

10.1001/jamaoncol.2016.4983

EISSN

2374-2445

Publication Date

July 1, 2017

Volume

3

Issue

7

Start / End Page

996 / 998

Location

United States

Related Subject Headings

  • Sequence Analysis, DNA
  • Reproducibility of Results
  • Neoplasms
  • Middle Aged
  • Male
  • Humans
  • High-Throughput Nucleotide Sequencing
  • Female
  • Exons
  • Cell-Free Nucleic Acids
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kuderer, N. M., Burton, K. A., Blau, S., Rose, A. L., Parker, S., Lyman, G. H., & Blau, C. A. (2017). Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology. JAMA Oncol, 3(7), 996–998. https://doi.org/10.1001/jamaoncol.2016.4983
Kuderer, Nicole M., Kimberly A. Burton, Sibel Blau, Andrea L. Rose, Stephanie Parker, Gary H. Lyman, and C Anthony Blau. “Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.” JAMA Oncol 3, no. 7 (July 1, 2017): 996–98. https://doi.org/10.1001/jamaoncol.2016.4983.
Kuderer NM, Burton KA, Blau S, Rose AL, Parker S, Lyman GH, et al. Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology. JAMA Oncol. 2017 Jul 1;3(7):996–8.
Kuderer, Nicole M., et al. “Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.” JAMA Oncol, vol. 3, no. 7, July 2017, pp. 996–98. Pubmed, doi:10.1001/jamaoncol.2016.4983.
Kuderer NM, Burton KA, Blau S, Rose AL, Parker S, Lyman GH, Blau CA. Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology. JAMA Oncol. 2017 Jul 1;3(7):996–998.

Published In

JAMA Oncol

DOI

10.1001/jamaoncol.2016.4983

EISSN

2374-2445

Publication Date

July 1, 2017

Volume

3

Issue

7

Start / End Page

996 / 998

Location

United States

Related Subject Headings

  • Sequence Analysis, DNA
  • Reproducibility of Results
  • Neoplasms
  • Middle Aged
  • Male
  • Humans
  • High-Throughput Nucleotide Sequencing
  • Female
  • Exons
  • Cell-Free Nucleic Acids